Bellevue Life Sciences Acquisition Corp. announced a private placement to issue unsecured non-convertible promissory note for gross proceeds of $1,200,000 on April 8, 2024. The transaction included participation from returning lender, Bellevue Global Life Sciences Investors, LLC.

The promissory note is not interest bearing and is payable in full on the earlier of December 31, 2024 or the date on which the company consummates an initial business combination.